Health Trials

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

1

Review clinical trials related to Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This is A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Participants needed: 132
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Antengene Biologics LimitedUpdated: Apr 14, 2026Locations: 30
Eligibility criteria

Provision of signed and dated, written informed consent prior to any study-speci... [+5]

Known active central nervous system metastases and/or carcinomatous meningitis.... [+6]

Read more